A Washington State-based biotech found quite a bit of success on Wednesday after Needham & Co. initiated coverage with a Buy rating and a $9 price target. This news came just...

To read the full story on AllPennyStocks.com, click here.

AbSci (NASDAQ:ABSI)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025 Plus de graphiques de la Bourse AbSci
AbSci (NASDAQ:ABSI)
Graphique Historique de l'Action
De Jan 2024 à Jan 2025 Plus de graphiques de la Bourse AbSci